Polycystic Ovary Syndrome: Explaining the Gynecological Aspects and Treatment Options to Patients
Journal Title: Journal of Endocrinology and Diabetes - Year 2015, Vol 2, Issue 4
Abstract
Polycystic Ovary Syndrome (PCOS) is one of the most prevalent conditions leading to reproductive and metabolic health concerns for women. The apparently disparate consequences of this disorder ranging from menstrual dysfunction to hirsutism, infertility and endometrial cancer create a confusing picture for clinicians and often result in an inadequate explanation for affected women. This article will provide a simple construct for PCOS which will allow health care providers to inform and motivate women in a way that optimizes treatment for these conditions.
Authors and Affiliations
Robert L Reid
Keywords
Related Articles
- EP ID EP333276
- DOI 10.15226/2374-6890/2/4/00132
- Views 111
- Downloads 0
A Comprehensive Nutriceutical Approach to Metabolic and Vascular Health
A composite nutriceutical containing extracts of Momordica charantia, pine bark extract, hematococcus pluvialis, red yeast rice, the antioxidants alpha-lipoic acid and oxidoreductase ubiquinone Q10, vitamins B9 and B12,...
Trends of Thyroid Cancer Mortality Rates in Ecuador
Objective: To analyze thyroid cancer (TC) mortality rates from 1990 to 2016 in Ecuadorian men and women and compare their trends with Latin American and international trends. Design: A population-based temporal-trend st...
Polycystic Ovary Syndrome: Explaining the Gynecological Aspects and Treatment Options to Patients
Polycystic Ovary Syndrome (PCOS) is one of the most prevalent conditions leading to reproductive and metabolic health concerns for women. The apparently disparate consequences of this disorder ranging from menstrual dysf...
Quality of Life of Patients Followed for Thyroid Cancer: An Element Not to Overlook
The quality of life has attracted great interest in recent years, primarily in patients followed for cancer. Differentiated thyroid cancer, despite its good prognosis, is responsible for a significant deterioration in t...
Effect of Beta - Blockers on Insulin Resistance in Patients with Hypertension and Metabolic Syndrome after 6 Months of Treatment
Background:For years the use of beta-blockers in patients with metabolic syndrome has been limited due to the negative impact of non-selective beta - blockers on carbohydrate and lipid metabolism. Aim:We studied antihyp...